RNA helicase DHX33 regulates HMGB family genes in human cancer cells

Cell Signal. 2023 Oct:110:110832. doi: 10.1016/j.cellsig.2023.110832. Epub 2023 Aug 4.

Abstract

RNA helicase DHX33 has been shown to be aberrantly expressed in various human cancers, however, its role in tumorigenesis remains incompletely understood. In this report, we uncovered that a family of DNA architecture proteins, HMGBs, can be regulated by DHX33 in cancer cells but not in normal cells. Specifically, DHX33 knockdown caused the downregulation of HMGBs at the levels of both gene transcription and protein expression. Notably, in RAS driven lung tumorigenesis, nuclear HMGBs proteins can be induced via DHX33. When DHX33 was knocked out, HMGBs overexpression was debilitated. Mechanistically, DHX33 was found to bind to the promoters of HMGB family genes and regulated their transcription through demethylation on gene promoters. Our study reveals a novel mechanism for DHX33 to promote tumorigenesis and highlights its therapeutic value in human cancers.

Keywords: DHX33; Epigenetic; HMGB; RNA helicase; cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinogenesis
  • Cell Transformation, Neoplastic
  • DEAD-box RNA Helicases / genetics
  • HMGB Proteins
  • Humans
  • Lung
  • Neoplasms*

Substances

  • HMGB Proteins
  • DHX33 protein, human
  • DEAD-box RNA Helicases